Since its inception, Lupin has continued to expand its leadership and global footprint in a strongly competitive business environment. We attribute this to our governance framework, which defines our principles and forms a strong foundation for sustainable growth. Our philosophy has always been to acknowledge, accept and adhere to the highest standards of ethical behavior and integrity, thereby building trust amongst all our stakeholders.
To embed business ethics within our culture, we reinforce PLEDGE - Preparing Lupin Employees to Demonstrate Corporate Governance and Ethical Conduct. The purpose of PLEDGE is to establish fundamental values as well as standards and guidelines that we expect our employees to abide by during their employment. It also provides an avenue for employees to voice their concerns as well as report any violation, misconduct, or malpractice without the fear of penalization or retribution. PLEDGE incorporates our ‘Code of Business Conduct and Ethics’ (the Code) that is applicable to all employees including the senior leadership, and the Board of Directors.
The Code reinforces our values of transparency, accountability, integrity, and professionalism, which are embedded in our company’s ethos and DNA. It is mandatory that employees acknowledge their receipt, acceptance, and observance of this Code so that they are aligned with our vision while pursuing their professional and personal goals.
A few of the core competencies that allow us to function efficiently are:
Our Board of Directors comprise of a group of highly experienced entrepreneurs and professionals from the pharmaceutical industry and beyond, who bring together a diverse set of skills from multiple backgrounds. The leadership team provides guidance, support and strategic direction to our senior management while monitoring the implementation of approved policies as well as efficient working of functional areas. They are responsible for ensuring that the highest standards of corporate governance are developed, implemented, and adhered to so that we adapt to the ever-evolving regulatory landscape.
Our Independent Directors, out of which two are women, are highly recognized global leaders with extensive knowledge and core competencies. With managerial and technical expertise spanning across industries, our Independent Directors provide inputs on the operational plans of the company as well as address multifaceted financial issues. With an in-depth and holistic knowledge of the global and domestic pharmaceutical industry, our Directors consistently equip us with their advice and insights. To date, there is no conflict of interest between the Independent Directors and Lupin.